Expeditionary Resilience in Extreme Conditions
Journal of Human Resources Management Research · 27.03.2026
DOI: 10.5171/2025.4635125 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Human Resources Management Research, online erschienen am 27.03.2026. Verfasst von Pawel B. MICHALSKI.
Abstract (Originalsprache)
The planned research project “Expeditionary Resilience in Extreme Conditions” aims to develop an interdisciplinary model of human and team resilience by integrating scientific research, mountaineering experience, and academic education. The study will focus on individuals and groups operating in high-risk, high-stress environments – such as mountaineering expeditions – where adaptation, decision-making, and teamwork are challenged under extreme conditions. Building on prior research conceptualizing resilience as a dynamic, multifactorial construct, the research will combine qualitative and quantitative methodologies to explore psychological coping strategies, physiological responses, and logistical management processes. It will extend existing findings on mountain resilience and human adaptation. The researcher’s dual expertise – as both a logistics scholar and experienced alpinist – enables a unique synthesis of theoretical knowledge and real-world practice. The outcomes will inform training tools, educational programs, and operational strategies for athletes, rescuers, and expedition teams, with broader implications for resilience in disaster response, military, and space missions.
Zitieren
APA
MICHALSKI, P. B. (2026). Expeditionary Resilience in Extreme Conditions. Journal of Human Resources Management Research. https://doi.org/10.5171/2025.4635125
Vancouver
MICHALSKI PB. Expeditionary Resilience in Extreme Conditions. Journal of Human Resources Management Research. 2026. doi:10.5171/2025.4635125
BibTeX
@article{MICHALSKI2026,
author = {MICHALSKI, Pawel B.},
title = {Expeditionary Resilience in Extreme Conditions},
journal = {Journal of Human Resources Management Research},
year = {2026},
doi = {10.5171/2025.4635125}
}
EUVIMED